Data is not available at this time.
Ryan Specialty Holdings, Inc. operates as a leading specialty insurance brokerage and underwriting firm, catering to niche markets with complex risk management needs. The company generates revenue primarily through brokerage fees, underwriting commissions, and risk advisory services, serving clients across property & casualty, professional liability, and specialty insurance lines. Its expertise in hard-to-place risks positions it as a key intermediary between insurers and high-demand sectors such as aviation, healthcare, and financial institutions. Ryan Specialty differentiates itself through deep technical underwriting capabilities, a diversified product portfolio, and a client-centric approach, reinforcing its competitive moat in the fragmented specialty insurance market. The firm’s vertically integrated model, combining wholesale brokerage with managing general underwriting (MGU) operations, enhances cross-selling opportunities and operational efficiency. Its strong relationships with global carriers and ability to structure bespoke solutions solidify its reputation as a trusted partner in high-stakes risk transfer.
Ryan Specialty reported revenue of $2.52 billion for FY 2024, reflecting its robust brokerage and underwriting activities. Net income stood at $94.7 million, with diluted EPS of $0.071, indicating moderate profitability amid competitive pressures. Operating cash flow of $514.9 million underscores healthy cash generation, while capital expenditures of -$47.0 million suggest disciplined investment in growth initiatives.
The company’s earnings power is supported by its diversified revenue streams and scalable underwriting platforms. While net margins appear modest, its capital-light brokerage model and efficient claims management contribute to steady returns. The firm’s ability to leverage its MGU partnerships enhances fee-based income without significant balance sheet risk.
Ryan Specialty holds $540.2 million in cash and equivalents, providing liquidity for operational needs. Total debt of $3.46 billion indicates leverage, though this is typical for insurance intermediaries funding growth. The balance sheet remains manageable given strong cash flow generation and a focus on recurring revenue streams.
Growth is driven by organic expansion in specialty lines and strategic acquisitions. The company pays a dividend of $0.46 per share, signaling commitment to shareholder returns, though payout ratios remain conservative to retain flexibility for reinvestment.
The market likely values Ryan Specialty for its niche expertise and resilient revenue model. Trading multiples may reflect expectations for sustained mid-single-digit growth and margin stability in a cyclical industry.
Ryan Specialty’s deep underwriting expertise and diversified client base position it well for long-term growth. Challenges include pricing competition and regulatory scrutiny, but its focus on complex risks and innovation in specialty products should sustain its market leadership.
Company filings (10-K), investor presentations
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |